BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dratkiewicz E, Simiczyjew A, Mazurkiewicz J, Ziętek M, Matkowski R, Nowak D. Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance. Cells 2021;10:862. [PMID: 33918883 DOI: 10.3390/cells10040862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Reference Citation Analysis]
2 Rauca VF, Patras L, Luput L, Licarete E, Toma VA, Porfire A, Mot AC, Rakosy-Tican E, Sesarman A, Banciu M. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression. Sci Rep 2021;11:22102. [PMID: 34764332 DOI: 10.1038/s41598-021-01284-5] [Reference Citation Analysis]
3 Khalyfa A, Trzepizur W, Gileles-Hillel A, Qiao Z, Sanz-Rubio D, Marin JM, Martinez-Garcia MA, Campos-Rodriguez F, Almendros I, Farre R, Sanchez-de-la-Torre M, García-Río F, Gozal D. Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia. Cancers (Basel) 2021;13:4781. [PMID: 34638272 DOI: 10.3390/cancers13194781] [Reference Citation Analysis]
4 Boussadia Z, Gambardella AR, Mattei F, Parolini I. Acidic and Hypoxic Microenvironment in Melanoma: Impact of Tumour Exosomes on Disease Progression. Cells 2021;10:3311. [PMID: 34943819 DOI: 10.3390/cells10123311] [Reference Citation Analysis]
5 Mazurkiewicz E, Makowiecka A, Mrówczyńska E, Kopernyk I, Nowak D, Mazur AJ. Gelsolin Contributes to the Motility of A375 Melanoma Cells and This Activity Is Mediated by the Fibrous Extracellular Matrix Protein Profile. Cells 2021;10:1848. [PMID: 34440617 DOI: 10.3390/cells10081848] [Reference Citation Analysis]
6 Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Pietraszek-Gremplewicz K, Majkowski M, Kot M, Ziętek M, Matkowski R, Nowak D. Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts. Cell Commun Signal 2022;20:63. [PMID: 35538545 DOI: 10.1186/s12964-022-00871-x] [Reference Citation Analysis]
7 Jung T, Haist M, Kuske M, Grabbe S, Bros M. Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond. Int J Mol Sci 2021;22:9890. [PMID: 34576054 DOI: 10.3390/ijms22189890] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Takabe P, Siiskonen H, Rönkä A, Kainulainen K, Pasonen-seppänen S. The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma. Front Oncol 2022;11:811434. [DOI: 10.3389/fonc.2021.811434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bychkov ML, Kirichenko AV, Mikhaylova IN, Paramonov AS, Yastremsky EV, Kirpichnikov MP, Shulepko MA, Lyukmanova EN. Extracellular Vesicles Derived from Acidified Metastatic Melanoma Cells Stimulate Growth, Migration, and Stemness of Normal Keratinocytes. Biomedicines 2022;10:660. [DOI: 10.3390/biomedicines10030660] [Reference Citation Analysis]
10 Bychkov ML, Kirichenko AV, Shulepko MA, Mikhaylova IN, Kirpichnikov MP, Lyukmanova EN. Mambalgin-2 Inhibits Growth, Migration, and Invasion of Metastatic Melanoma Cells by Targeting the Channels Containing an ASIC1a Subunit Whose Up-Regulation Correlates with Poor Survival Prognosis. Biomedicines 2021;9:1324. [PMID: 34680442 DOI: 10.3390/biomedicines9101324] [Reference Citation Analysis]